Helmut Glantschnig

1.6k total citations
32 papers, 1.1k citations indexed

About

Helmut Glantschnig is a scholar working on Molecular Biology, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Helmut Glantschnig has authored 32 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 10 papers in Oncology and 9 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Helmut Glantschnig's work include Bone Metabolism and Diseases (10 papers), Bone health and treatments (8 papers) and Growth Hormone and Insulin-like Growth Factors (7 papers). Helmut Glantschnig is often cited by papers focused on Bone Metabolism and Diseases (10 papers), Bone health and treatments (8 papers) and Growth Hormone and Insulin-like Growth Factors (7 papers). Helmut Glantschnig collaborates with scholars based in Austria, United States and United Kingdom. Helmut Glantschnig's co-authors include Gideon A. Rodan, John Fisher, Gregg Wesolowski, A A Reszka, Franz Varga, Alfred A. Reszka, K. Klaushofer, Eva Luegmayr, M. Rumpler and Nadja Fratzl‐Zelman and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Helmut Glantschnig

32 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Helmut Glantschnig Austria	15	652	367	181	165	160	32	1.1k
Leah M. Helvering United States	14	599 0.9×	269 0.7×	117 0.6×	112 0.7×	52 0.3×	17	999
M. Machwate France	13	526 0.8×	273 0.7×	169 0.9×	92 0.6×	71 0.4×	14	865
Shibing Yu United States	17	601 0.9×	275 0.7×	71 0.4×	130 0.8×	49 0.3×	25	965
Emel Esen United States	9	662 1.0×	206 0.6×	104 0.6×	98 0.6×	55 0.3×	10	965
Tamara C. Murphy United States	22	802 1.2×	212 0.6×	145 0.8×	95 0.6×	92 0.6×	28	1.4k
Vien Le United States	11	595 0.9×	163 0.4×	130 0.7×	154 0.9×	45 0.3×	20	1.2k
Antigone Sourla Greece	24	504 0.8×	432 1.2×	62 0.3×	108 0.7×	356 2.2×	52	1.4k
Miwa Yamazaki Japan	20	637 1.0×	205 0.6×	80 0.4×	64 0.4×	191 1.2×	32	1.3k
Weiguang Zhao United States	11	1.1k 1.7×	418 1.1×	186 1.0×	69 0.4×	53 0.3×	15	1.7k
Nisan Bhattacharyya United States	19	670 1.0×	443 1.2×	83 0.5×	50 0.3×	233 1.5×	29	1.5k

Countries citing papers authored by Helmut Glantschnig

Since Specialization

Citations

This map shows the geographic impact of Helmut Glantschnig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helmut Glantschnig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helmut Glantschnig more than expected).

Fields of papers citing papers by Helmut Glantschnig

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helmut Glantschnig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helmut Glantschnig. The network helps show where Helmut Glantschnig may publish in the future.

Co-authorship network of co-authors of Helmut Glantschnig

This figure shows the co-authorship network connecting the top 25 collaborators of Helmut Glantschnig. A scholar is included among the top collaborators of Helmut Glantschnig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helmut Glantschnig. Helmut Glantschnig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rossato, Paolo, Helmut Glantschnig, Fabio Canneva, et al.. (2023). Treatment with recombinant ADAMTS13, alleviates hypoxia/reoxygenation-induced pathologies in a mouse model of human sickle cell disease. Journal of Thrombosis and Haemostasis. 21(2). 269–275. 5 indexed citations

Rossato, Paolo, Enrica Federti, Alessandro Mattè, et al.. (2022). Evidence of protective effects of recombinant ADAMTS13 in a humanized model of sickle cell disease. Haematologica. 107(11). 2650–2660. 13 indexed citations

Rossato, Paolo, Helmut Glantschnig, Tanja Ruthsatz, et al.. (2021). Absence of exaggerated pharmacology by recombinant ADAMTS13 in the rat and monkey. Blood Coagulation & Fibrinolysis. 33(1). 56–60. 3 indexed citations

Glantschnig, Helmut, Michael Dockal, Veronika Ehrlich, et al.. (2019). Evaluation of Factor VIII Polysialylation: Identification of a Longer-Acting Experimental Therapy in Mice and Monkeys. Journal of Pharmacology and Experimental Therapeutics. 371(1). 95–105. 3 indexed citations

Ma, Bennett, Bin Luo, Gregg Wesolowski, et al.. (2017). Applicability of in vitro-in vivo translation of cathepsin K inhibition from animal species to human with the use of free-drug hypothesis. Naunyn-Schmiedeberg s Archives of Pharmacology. 390(4). 435–441. 9 indexed citations

Baumgartner, Bernhard, Barbara Dietrich, Patrice Douillard, et al.. (2017). Pharmacokinetics, disease-modifying activity, and safety of an experimental therapeutic targeting an immunological isoform of macrophage migration inhibitory factor, in rat glomerulonephritis. European Journal of Pharmacology. 820. 206–216. 5 indexed citations

Fisher, John, Kevin R. Scott, Nan Wei, et al.. (2012). Pharmacodynamic Responses to combined treatment regimens with the calcium sensing receptor antagonist JTT-305/MK-5442 and alendronate in osteopenic ovariectomized rats. Bone. 50(6). 1332–1342. 10 indexed citations

Glantschnig, Helmut, Kevin R. Scott, Richard Hampton, et al.. (2011). A Rate-Limiting Role for Dickkopf-1 in Bone Formation and the Remediation of Bone Loss in Mouse and Primate Models of Postmenopausal Osteoporosis by an Experimental Therapeutic Antibody. Journal of Pharmacology and Experimental Therapeutics. 338(2). 568–578. 71 indexed citations

Beaumont, Vahri, Hugh Nuthall, Helmut Glantschnig, et al.. (2007). Evidence for an enhancement of excitatory transmission in adult CNS by Wnt signaling pathway modulation. Molecular and Cellular Neuroscience. 35(4). 513–524. 35 indexed citations

10.

Luegmayr, Eva, Helmut Glantschnig, Gregg Wesolowski, et al.. (2004). Osteoclast formation, survival and morphology are highly dependent on exogenous cholesterol/lipoproteins. Cell Death and Differentiation. 11(S1). S108–S118. 115 indexed citations

11.

Fratzl‐Zelman, Nadja, Helmut Glantschnig, M. Rumpler, et al.. (2003). The expression of matrix metalloproteinase‐13 and osteocalcin in mouse osteoblasts is related to osteoblastic differentiation and is modulated by 1,25‐dihydroxyvitamin D3 and thyroid hormones. Cell Biology International. 27(6). 459–468. 31 indexed citations

12.

Glantschnig, Helmut, John Fisher, Gregg Wesolowski, Gideon A. Rodan, & A A Reszka. (2003). M-CSF, TNFα and RANK ligand promote osteoclast survival by signaling through mTOR/S6 kinase. Cell Death and Differentiation. 10(10). 1165–1177. 287 indexed citations

13.

Glantschnig, Helmut, Gideon A. Rodan, & Alfred A. Reszka. (2002). Mapping of MST1 Kinase Sites of Phosphorylation. Journal of Biological Chemistry. 277(45). 42987–42996. 153 indexed citations

14.

Luegmayr, Eva, Helmut Glantschnig, Franz Varga, & Klaus Klaushofer. (2000). The organization of adherens junctions in mouse osteoblast-like cells (MC3T3-E1) and their modulation by triiodothyronine and 1,25-dihydroxyvitamin D3. Histochemistry and Cell Biology. 113(6). 467–478. 20 indexed citations

15.

Varga, Franz, Eva Luegmayr, Nadja Fratzl‐Zelman, et al.. (1999). Tri-iodothyronine inhibits multilayer formation of the osteoblastic cell line, MC3T3-E1, by promoting apoptosis. Journal of Endocrinology. 160(1). 57–65. 21 indexed citations

16.

Klaushofer, K., et al.. (1999). [Osteoporosis and metabolic bone diseases; clinical relationship].. PubMed. 149(16-17). 463–71. 4 indexed citations

17.

Glantschnig, Helmut, Franz Varga, Eva Luegmayr, & Klaus Klaushofer. (1998). Characterization of the Mouse Insulin-Like Growth Factor Binding Protein 4 Gene Regulatory Region and Expression Studies. DNA and Cell Biology. 17(1). 51–60. 13 indexed citations

18.

Varga, Franz, M. Rumpler, Eva Luegmayr, et al.. (1997). Triiodothyronine, a Regulator of Osteoblastic Differentiation: Depression of Histone H4, Attenuation of c-fos/c-jun, and Induction of Osteocalcin Expression. Calcified Tissue International. 61(5). 404–411. 64 indexed citations

19.

Glantschnig, Helmut, Franz Varga, M. Rumpler, & K. Klaushofer. (1996). Prostacyclin (PGI₂): a potential mediator of c‐fos expression induced by hydrostatic pressure in osteoblastic cells . European Journal of Clinical Investigation. 26(7). 544–548. 39 indexed citations

20.

Klaushofer, K., Franz Varga, Helmut Glantschnig, et al.. (1995). The Regulatory Role of Thyroid Hormones in Bone Cell Growth and Differentiation. Journal of Nutrition. 125(7 Suppl). 1996S–2003S. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact